- Report
- March 2025
- 181 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- April 2022
- 204 Pages
Global
From €4551EUR$5,000USD£3,901GBP
Diastolic heart failure is a type of heart failure in which the heart's left ventricle is unable to fill with enough blood during diastole, the period of relaxation between heartbeats. This can lead to a decrease in cardiac output, resulting in symptoms such as shortness of breath, fatigue, and swelling of the legs and feet. Treatment for diastolic heart failure typically involves lifestyle modifications such as reducing salt intake, quitting smoking, and exercising regularly. Medications such as diuretics, ACE inhibitors, and beta-blockers may also be prescribed to reduce symptoms and improve quality of life.
Companies in the diastolic heart failure market include AstraZeneca, Bayer, Boehringer Ingelheim, GlaxoSmithKline, Merck & Co., Novartis, Pfizer, Sanofi, and Takeda. Show Less Read more